The Saudi National Institute of Health signed a Memorandum of Understanding (MoU) with French pharmaceutical company Sanofi on the sidelines of the Saudi-French Investment Forum in Paris. The MoU was signed by Dr. Fares Al-Enezi, CEO of the National Institute for Health Research, and Olivier Charmeil, Executive Vice President at Sanofi.
The MoU aims to strengthen cooperation in research and development, innovation, and clinical research, while fostering partnerships between the public and private sectors. It will support the development of promising therapeutic solutions and health technologies, strengthen the health research and innovation ecosystem, and enhance research capabilities, in line with the objectives of the Health Sector Transformation Program under Saudi Vision 2030.
The MoU builds on the longstanding relations between Saudi Arabia and France and reflects both sides' commitment to exchanging expertise and developing high-impact partnerships that contribute to advancing clinical research, promoting innovation, and translating research outputs into innovative and sustainable health solutions that serve human health.